Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01074918

Potassium-Magnesium Citrate as a Blood Pressure Lowering Agent in Hypertensive Patients

Potassium-Magnesium Citrate as a Blood Pressure Lowering Agent in Hypertensive Patients; Role of Natriuresis

Status
Withdrawn
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Texas Southwestern Medical Center · Academic / Other
Sex
All
Age
21 Years – 95 Years
Healthy volunteers
Accepted

Summary

The goal of this study is to compare the effects of Potassium Magnesium Citrate to Potassium Chloride on blood pressure among patients with pre-hypertension or mild hypertension. We will also test whether Potassium Magnesium Citrate increases excretion of large amounts of sodium in the urine.

Conditions

Interventions

TypeNameDescription
DRUGPotassium, Magnesium, CitratePotassium MAgnesium Citrate - 30 mEq potassium, 15 mEq Magnesium, 45 mEq Citrate in a powder mixture twice a day, mixed with a glass of water.
DRUGPotassium ChloridePotassium Chloride

Timeline

Start date
2009-09-01
Primary completion
2012-09-01
Completion
2012-12-01
First posted
2010-02-24
Last updated
2019-02-11

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01074918. Inclusion in this directory is not an endorsement.